Literature DB >> 24009960

Histological grading and staging of liver and its relation to viral loads in chronic anti-HBe positive hepatitis.

Shahriar Shafaei1, Shima Soleimani Amiri, Mahmoud Hajiahmadi, Mahmoud Sadeghi-Haddad-Zavareh, Masomeh Bayani.   

Abstract

BACKGROUND: Hepatitis activity index (HAI) and fibrosing stage are two important findings during the evaluation of liver samples in patients with chronic hepatitis B. The aim of this study was to determine the HAI and fibrosing stage in patients with anti-HBe positive chronic hepatitis B.
METHODS: Liver biopsy slides of 72 patients were evaluated at the Department of Pathology in two teaching hospitals of Babol University of Medical Sciences, Iran, from April 2006 to August 2011. Total HAI or grading as well as its components including piecemeal necrosis, confluent necrosis, spoty necrosis, portal inflammation and fibrosis scores or staging in considering with viral loads more or less than 10(5) copies/ml were enumerated according to Ishak scoring system.
RESULTS: The mean age of these patients was 34.4±12 years. Fifty-six patients had viral load> 10(5) copies/ml. Piecemeal necrosis and grading scores with viral load (10(3),10(3)-10(5) and >10(5) copies/ml) were 0.8±0.7, 0.9±0.4, 1.8±1 and 3.8±1.9, 4.4±2, 5.9±2.6, respectively (p=0.005 and p=0.04, respectively). There was not any significant difference with fibrosis stage regarding different viral loads. In total, 18 cases had fibrosis scores > 1 and 24 cases had confluent necrosis. HAI≥4 was seen in 29 (60.4%) of the 48 cases without confluent necrosis and in 23 out of 24 cases with confluent necrosis (p=0.007).
CONCLUSION: The results show that piecemeal necrosis and higher grading scores are associated with higher viral loads. The presence of confluent necrosis is associated with more severe diseases.

Entities:  

Keywords:  Confluent necrosis; Grade; Stage; Viral load

Year:  2013        PMID: 24009960      PMCID: PMC3755837     

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


  19 in total

1.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

Review 2.  Management of hepatitis B: 2000--summary of a workshop.

Authors:  A S Lok; E J Heathcote; J H Hoofnagle
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

3.  Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

Authors:  Maurizia Rossana Brunetto; Filippo Oliveri; Piero Colombatto; Francesco Moriconi; Pietro Ciccorossi; Barbara Coco; Veronica Romagnoli; Beatrice Cherubini; Giovanna Moscato; Anna Maria Maina; Daniela Cavallone; Ferruccio Bonino
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

Review 4.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

Review 5.  Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review.

Authors:  George V Papatheodoridis; Spilios Manolakopoulos; Yun-Fan Liaw; Anna Lok
Journal:  J Hepatol       Date:  2012-03-23       Impact factor: 25.083

6.  A survey of liver pathology in needle biopsies from HBsAg and anti-HBe positive individuals.

Authors:  F ter Borg; F J ten Kate; H T Cuypers; A Leentvaar-Kuijpers; J Oosting; P M Wertheim-van Dillen; P Honkoop; M C Rasch; R A de Man; J van Hattum; R A Chamuleau; G N Tytgat; E A Jones
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

7.  Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection.

Authors:  Emanuel K Manesis; George V Papatheodoridis; Vasilios Sevastianos; Evangelos Cholongitas; Christos Papaioannou; Stephanos J Hadziyannis
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

8.  Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.

Authors:  Guido Colloredo; Maria Guido; Aurelio Sonzogni; Gioacchino Leandro
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

Review 9.  Management of hepatitis B: summary of a clinical research workshop.

Authors:  Jay H Hoofnagle; Edward Doo; T Jake Liang; Russell Fleischer; Anna S F Lok
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

10.  Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

Authors:  Jordan J Feld; Melissa Ayers; Dahlia El-Ashry; Tony Mazzulli; Raymond Tellier; E Jenny Heathcote
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

View more
  5 in total

1.  Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis.

Authors:  Suxia Bao; Jianming Zheng; Ning Li; Chong Huang; Mingquan Chen; Qi Cheng; Kangkang Yu; Shengshen Chen; Mengqi Zhu; Guangfeng Shi
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

2.  Persistence of immunity to hepatitis B vaccine as infants, 17 years earlier.

Authors:  Zohreh Azarkar; Azadeh Ebrahimzadeh; Gholamreza Sharifzadeh; Masood Ziaee; Mohammad Fereidouni; Fatemeh Taheri
Journal:  Caspian J Intern Med       Date:  2018

3.  The Influence of Histologic Inflammation on the Improvement of Liver Stiffness Values Over 1 and 3 Years.

Authors:  Jeong-Ju Yoo; Yeon Seok Seo; Young Seok Kim; Soung Won Jeong; Jae Young Jang; Sang Jun Suh; Hyung Joon Yim; Ki Tae Suk; Dong Joon Kim; Kwang-Hyub Han; Seung Up Kim; Bora Lee; Sang Gyune Kim
Journal:  J Clin Med       Date:  2019-11-24       Impact factor: 4.241

4.  Negative Correlation Between Hepatitis C Virus (HCV) and Let-7 MicroRNA Family in Transplanted Livers: The Role of rs868 Single-Nucleotide Polymorphism.

Authors:  Emir Ahmed Sajjad; Marek Radkowski; Agnieszka Perkowska-Ptasińska; Marek Pacholczyk; Magdalena Durlik; Mikołaj Fedorowicz; Renata Pietrzak; Bogna Ziarkiewicz-Wróblewska; Paweł Włodarski; Jacek Malejczyk
Journal:  Ann Transplant       Date:  2017-10-24       Impact factor: 1.530

5.  Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?

Authors:  Ercan Yenilmez; Rıza Aytaç Çetinkaya; Ersin Tural
Journal:  Balkan Med J       Date:  2018-05-04       Impact factor: 2.021

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.